Compound	Ginsenoside Rg3
NPACT-Id	NPACT01120
IUPAC	2-[4,5-dihydroxy-2-[[12-hydroxy-17-(2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-yclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
Synonyms	2-(hydroxymethyl)-6-[6-(hydroxymethyl)-4,5-bis(oxidanyl)-2-[[4,4,8,10,14-pentamethyl-17-(6-methyl-2-oxidanyl-hept-5-en-2-yl)-12-oxidanyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-oxane-3,4,5-triol;2-[[4,5-dihydroxy-2-[[12-hydroxy-17-(2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)-3-oxanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
PubChem Id	12901617
Class	Terpenoids
In-vitro anticancer activity	1 cancer cell lines
In-Vivo anticancer activity	No
Targets	BAX \| BCL2 \| BIRC2 \| CASP3 \| CASP9 \| NFKB1 \| XIAP \| All \|
Properties	Physical Elemental Topological
InChi Key	RWXIFXNRCLMQCD-UHFFFAOYSA-N
InChi	1S/C42H72O13/c1-21(2)10-9-14-42(8,51)22-11-16-41(7)29(22)23(45)18-27-39(5)15-13-28(38(3,4)26(39)12-17-40(27,41)6)54-37-35(33(49)31(47)25(20-44)53-37)55-36-34(50)32(48)30(46)24(19-43)52-36/h10,22-37,43-51H,9,11-20H2,1-8H3
SMILES	OC1C2C(C3(C(C4(C(CC3)C(C(OC3OC(C(O)C(O)C3OC3OC(C(O)C(O)C3O)CO)CO)CC4)(C)C)C)C1)C)(CCC2C(O)(CCC=C(C)C)C)C
SMART	[#6]C([#6])=CCCC([#6])(O)C1CCC2([#6])C1C(O)CC1C3([#6])CCC(OC4OC(CO)C(O)C(O)C4OC4OC(CO)C(O)C(O)C4O)C([#6])([#6])C3CCC21[#6]
CAS No.	14197-60-5
Structure Download
Cross Refrence in other databases
	Super Natural	-
	CTD	C097367
	HIT	-
	NCI-60 GI₅₀ data	-
Suppliers	NA,
Drug-Likeliness Filters	Lipinski's rule of five	No
	Ghose filter	No
	Veber filter	No
	Muegge Filter	No
Similarity Search	Human metabolite database	FDA approved drugs

NPACT

Naturally occuring Plant based Anticancerous Compound-Activity-Target DataBase

Help

FAQs

Statistics

Tool

Contact